Shopping Cart 0
Cart Subtotal
USD 0

GenePOC Inc - Product Pipeline Analysis, 2018 Update

Restricted to one authorized user; Open on 1 PC/ mobile / Tablet only.
Print Option: Yes
Copy Option: No
Deliverable Format : PDF Via Email

Single User License
USD 750

Restricted to one authorized user; Open on 1 PC/ mobile / Tablet only.
Print Option: Yes
Copy Option: No
Deliverable Format : PDF Via Email

Site License
USD 1500

Multiple Users within the Company/ Enterprise
Print Option: Yes
Copy Option: Yes
Deliverable Format : Excel, PDF Via Email

Corporate User License
USD 2250

Details

Summary

GenePOC Inc (GenePOC), a subsidiary of Debiopharm Group, is a medical device company that develops rapid molecular devices for providing targeted therapy. The company offers on-the-spot diagnostic devices for achieving optimal patient management. It offers diagnostic instruments based on a novel centripetal technology platform. GenePOC also provides automated point-of-care molecular diagnostic system that facilitates early detection and the prevention of infectious diseases. The company's POC diagnostic system is employed in the detection of respiratory tract infections, neonatal infections, gastrointestinal tract, and others. GenePOC is headquartered in Quebec City, Quebec, Canada.

This report is a source for data, analysis, and actionable intelligence on the company's portfolio of pipeline products. The report provides key information about the company, its major products and brands.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.

Scope:

- The report reviews detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments

- The report analyzes all pipeline products in development for the company GenePOC Inc

- The report provides pipeline analysis on all pipeline products of the company (by equipment type, by indication, by development stage, and by trial status)

- The report covers detailed information on each pipeline product with information on pipeline territory, stage of development, device class, regulatory path, indication(s), application(s) and estimated launch date

- The report provides detailed description of products in development, technical specification and functions

- The report also covers ongoing clinical trials (wherever applicable) with information on trial name, trial objective, sponsor, trial design , trial status and phase, estimated start and end date.

Reasons to Buy:

- Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape

- Design and develop your product development, marketing and sales strategies by understanding the competitor portfolio

- To formulate effective Research & Development strategies

- Develop market-entry and market expansion strategies

- Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return

- Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline

- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage

- Develop competition strategies by identifying the status and likely launch of the competitors' pipeline products through review of the clinical trials, stage and of development, etc

- Identify, understand and capitalize the next high-value products that your competitor would add in its portfolio

Note: Some sections may be missing if data is unavailable for the company

READ MORE

Table Of Content

Scope

Table of Contents

Table of Contents 2

List of Tables 4

List of Figures 4

GenePOC Inc Company Overview 5

GenePOC Inc Company Snapshot 5

GenePOC Inc Pipeline Products and Ongoing Clinical Trials Overview 5

GenePOC Inc-Pipeline Analysis Overview 8

GenePOC Inc-Key Facts 8

GenePOC Inc-Major Products and Services 9

GenePOC Inc Pipeline Products by Development Stage 10

GenePOC Inc Ongoing Clinical Trials by Trial Status 13

GenePOC Inc Pipeline Products Overview 15

GenePOC GBS DS Assay 15

GenePOC GBS DS Assay Product Overview 15

GenePOC GBS DS Assay Clinical Trial 16

revogene-Bacillus atrophaeus subsp. globigii Assay 17

revogene-Bacillus atrophaeus subsp. globigii Assay Product Overview 17

revogene-Bacillus subtilis Assay 18

revogene-Bacillus subtilis Assay Product Overview 18

revogene-Campylobacter jejuni Assay 19

revogene-Campylobacter jejuni Assay Product Overview 19

revogene-Candida albicans Assay 20

revogene-Candida albicans Assay Product Overview 20

revogene-Clostridium difficile Assay 21

revogene-Clostridium difficile Assay Product Overview 21

revogene-Enterococcus faecalis Assay 22

revogene-Enterococcus faecalis Assay Product Overview 22

revogene-Escherichia coli Assay 23

revogene-Escherichia coli Assay Product Overview 23

revogene-Influenza A Assay 24

revogene-Influenza A Assay Product Overview 24

revogene-Respiratory Tract Infections Assay 25

revogene-Respiratory Tract Infections Assay Product Overview 25

revogene-Salmonella enterica Assay 26

revogene-Salmonella enterica Assay Product Overview 26

revogene-Sexually Transmitted Infections Assay 27

revogene-Sexually Transmitted Infections Assay Product Overview 27

revogene-Staphylococcus Assay 28

revogene-Staphylococcus Assay Product Overview 28

Triplex Molecular Diagnostic Assay 29

Triplex Molecular Diagnostic Assay Product Overview 29

GenePOC Inc-Key Competitors 30

GenePOC Inc-Key Employees 31

GenePOC Inc-Locations And Subsidiaries 32

Head Office 32

Other Locations & Subsidiaries 32

Recent Developments 33

GenePOC Inc, Recent Developments 33

Mar 22, 2018: Novacyt Signs Assay Development Contract for Diagnosis of Respiratory Infections with GenePOC 33

Feb 19, 2018: GenePOC Launches Its revogene Instrument and GBS LB Test in Canada 33

Nov 28, 2017: GenePOC Launches Its GenePOC CDiff Test In The United States 34

Oct 12, 2017: GenePOC Launches its new GenePOC GBS DS Test 35

Sep 27, 2017: Genepoc to Attend EMMD in Noortwijk, the Netherlands, From October 11th to 13th 35

Jun 01, 2017: GenePOC announces FDA clearance for GBS LB test 36

Feb 02, 2017: GenePOC Announces GenePOC GBS Assay Launch in Europe and Middle East 36

Feb 02, 2017: GenePOC announces launch of CE-IVD marked test GenePOC CDiff in Europe and Middle East 37

Jan 11, 2017: GenePOC Announces CE Marking for its Revogene Instrument 37

Jan 11, 2017: GenePOC Announces CE Marking for its Second Bacteriological Test, GenePOC CDiff 37

Appendix 39

Methodology 39

About GlobalData 42

Contact Us 42

Disclaimer 42


List Of Figure

List of Figures

GenePOC Inc Pipeline Products by Equipment Type 6

GenePOC Inc Pipeline Products by Development Stage 10

GenePOC Inc Ongoing Clinical Trials by Trial Status 13


List Of Table

List of Tables

GenePOC Inc Pipeline Products and Ongoing Clinical Trials Overview 5

GenePOC Inc Pipeline Products by Equipment Type 6

GenePOC Inc Pipeline Products by Indication 7

GenePOC Inc Ongoing Clinical Trials by Trial Status 7

GenePOC Inc, Key Facts 8

GenePOC Inc, Major Products and Services 9

GenePOC Inc Number of Pipeline Products by Development Stage 10

GenePOC Inc Pipeline Products Summary by Development Stage 11

GenePOC Inc Ongoing Clinical Trials by Trial Status 13

GenePOC Inc Ongoing Clinical Trials Summary 14

GenePOC GBS DS Assay-Product Status 15

GenePOC GBS DS Assay-Product Description 15

GenePOC GBS DS Assay-Prospective Study for Clinical Validation of the Molecular-based GenePOC Carba Assay for the Detection and Differentiation of Carbapenemase Genes of Gram-negative Bacteria (blaIMP, blaKPC, blaNDM, blaOXA-48-like and blaVIM) in Rectal Swab Samples From Patients Suspected of Being Colonized. The Targeted Organisms are Enterobacteriaceae, Acinetobacter Baumannii, and Pseudomonas Aeruginosa 16

revogene-Bacillus atrophaeus subsp. globigii Assay-Product Status 17

revogene-Bacillus atrophaeus subsp. globigii Assay-Product Description 17

revogene-Bacillus subtilis Assay-Product Status 18

revogene-Bacillus subtilis Assay-Product Description 18

revogene-Campylobacter jejuni Assay-Product Status 19

revogene-Campylobacter jejuni Assay-Product Description 19

revogene-Candida albicans Assay-Product Status 20

revogene-Candida albicans Assay-Product Description 20

revogene-Clostridium difficile Assay-Product Status 21

revogene-Clostridium difficile Assay-Product Description 21

revogene-Enterococcus faecalis Assay-Product Status 22

revogene-Enterococcus faecalis Assay-Product Description 22

revogene-Escherichia coli Assay-Product Status 23

revogene-Escherichia coli Assay-Product Description 23

revogene-Influenza A Assay-Product Status 24

revogene-Influenza A Assay-Product Description 24

revogene-Respiratory Tract Infections Assay-Product Status 25

revogene-Respiratory Tract Infections Assay-Product Description 25

revogene-Salmonella enterica Assay-Product Status 26

revogene-Salmonella enterica Assay-Product Description 26

revogene-Sexually Transmitted Infections Assay-Product Status 27

revogene-Sexually Transmitted Infections Assay-Product Description 27

revogene-Staphylococcus Assay-Product Status 28

revogene-Staphylococcus Assay-Product Description 28

Triplex Molecular Diagnostic Assay-Product Status 29

Triplex Molecular Diagnostic Assay-Product Description 29

GenePOC Inc, Key Employees 31

GenePOC Inc, Other Locations 32

Glossary 41

Licence Rights

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License: 
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

Section Purchase

To know more information on Purchase by Section, please send a mail to support@kenresearch.com

INQUIRE FOR COVID-19 IMPACT ANALYSIS

Products and Companies

Products

GenePOC Inc, Product, Pipeline, Product Pipeline, Key Pipeline, Products by Equipment Type, Equipment Type, Therapy Area, Products by Therapy Area, Development Stage, Products by Development Stage, Milestone, Products by Milestone, Major Products, Brands, No of Products, Device Class, Market, Territory, Product Name, Therapy Name, Trial Name, Trial, Indication, Summary, Event Type, Clinical Trial, MileStone, Product Status, Product Description, Description, Patent, Patent Details, Competitors, Key Employees, Subsidiaries, Locations, News, Events, Developments, medical devices, business description, company facts, trial phase, approval, estimated, technology, product patent details, phase, trial status, trial objective, trial design, trial site, business strategies, trends, pipeline and technology, sales strategies


Companies

Xagenic Inc

Diagnostics Biochem Canada Inc

Rna Diagnostics Inc

Amico Corp

Company Profile

Company Profile Title

Summary

GenePOC Inc (GenePOC), a subsidiary of Debiopharm Group, is a medical device company that develops rapid molecular devices for providing targeted therapy. The company offers on-the-spot diagnostic devices for achieving optimal patient management. It offers diagnostic instruments based on a novel centripetal technology platform. GenePOC also provides automated point-of-care molecular diagnostic system that facilitates early detection and the prevention of infectious diseases. The company's POC diagnostic system is employed in the detection of respiratory tract infections, neonatal infections, gastrointestinal tract, and others. GenePOC is headquartered in Quebec City, Quebec, Canada.

This report is a source for data, analysis, and actionable intelligence on the company's portfolio of pipeline products. The report provides key information about the company, its major products and brands.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.

Scope:

- The report reviews detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments

- The report analyzes all pipeline products in development for the company GenePOC Inc

- The report provides pipeline analysis on all pipeline products of the company (by equipment type, by indication, by development stage, and by trial status)

- The report covers detailed information on each pipeline product with information on pipeline territory, stage of development, device class, regulatory path, indication(s), application(s) and estimated launch date

- The report provides detailed description of products in development, technical specification and functions

- The report also covers ongoing clinical trials (wherever applicable) with information on trial name, trial objective, sponsor, trial design , trial status and phase, estimated start and end date.

Reasons to Buy:

- Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape

- Design and develop your product development, marketing and sales strategies by understanding the competitor portfolio

- To formulate effective Research & Development strategies

- Develop market-entry and market expansion strategies

- Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return

- Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline

- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage

- Develop competition strategies by identifying the status and likely launch of the competitors' pipeline products through review of the clinical trials, stage and of development, etc

- Identify, understand and capitalize the next high-value products that your competitor would add in its portfolio

Note: Some sections may be missing if data is unavailable for the company

READ MORE

Scope

Table of Contents

Table of Contents 2

List of Tables 4

List of Figures 4

GenePOC Inc Company Overview 5

GenePOC Inc Company Snapshot 5

GenePOC Inc Pipeline Products and Ongoing Clinical Trials Overview 5

GenePOC Inc-Pipeline Analysis Overview 8

GenePOC Inc-Key Facts 8

GenePOC Inc-Major Products and Services 9

GenePOC Inc Pipeline Products by Development Stage 10

GenePOC Inc Ongoing Clinical Trials by Trial Status 13

GenePOC Inc Pipeline Products Overview 15

GenePOC GBS DS Assay 15

GenePOC GBS DS Assay Product Overview 15

GenePOC GBS DS Assay Clinical Trial 16

revogene-Bacillus atrophaeus subsp. globigii Assay 17

revogene-Bacillus atrophaeus subsp. globigii Assay Product Overview 17

revogene-Bacillus subtilis Assay 18

revogene-Bacillus subtilis Assay Product Overview 18

revogene-Campylobacter jejuni Assay 19

revogene-Campylobacter jejuni Assay Product Overview 19

revogene-Candida albicans Assay 20

revogene-Candida albicans Assay Product Overview 20

revogene-Clostridium difficile Assay 21

revogene-Clostridium difficile Assay Product Overview 21

revogene-Enterococcus faecalis Assay 22

revogene-Enterococcus faecalis Assay Product Overview 22

revogene-Escherichia coli Assay 23

revogene-Escherichia coli Assay Product Overview 23

revogene-Influenza A Assay 24

revogene-Influenza A Assay Product Overview 24

revogene-Respiratory Tract Infections Assay 25

revogene-Respiratory Tract Infections Assay Product Overview 25

revogene-Salmonella enterica Assay 26

revogene-Salmonella enterica Assay Product Overview 26

revogene-Sexually Transmitted Infections Assay 27

revogene-Sexually Transmitted Infections Assay Product Overview 27

revogene-Staphylococcus Assay 28

revogene-Staphylococcus Assay Product Overview 28

Triplex Molecular Diagnostic Assay 29

Triplex Molecular Diagnostic Assay Product Overview 29

GenePOC Inc-Key Competitors 30

GenePOC Inc-Key Employees 31

GenePOC Inc-Locations And Subsidiaries 32

Head Office 32

Other Locations & Subsidiaries 32

Recent Developments 33

GenePOC Inc, Recent Developments 33

Mar 22, 2018: Novacyt Signs Assay Development Contract for Diagnosis of Respiratory Infections with GenePOC 33

Feb 19, 2018: GenePOC Launches Its revogene Instrument and GBS LB Test in Canada 33

Nov 28, 2017: GenePOC Launches Its GenePOC CDiff Test In The United States 34

Oct 12, 2017: GenePOC Launches its new GenePOC GBS DS Test 35

Sep 27, 2017: Genepoc to Attend EMMD in Noortwijk, the Netherlands, From October 11th to 13th 35

Jun 01, 2017: GenePOC announces FDA clearance for GBS LB test 36

Feb 02, 2017: GenePOC Announces GenePOC GBS Assay Launch in Europe and Middle East 36

Feb 02, 2017: GenePOC announces launch of CE-IVD marked test GenePOC CDiff in Europe and Middle East 37

Jan 11, 2017: GenePOC Announces CE Marking for its Revogene Instrument 37

Jan 11, 2017: GenePOC Announces CE Marking for its Second Bacteriological Test, GenePOC CDiff 37

Appendix 39

Methodology 39

About GlobalData 42

Contact Us 42

Disclaimer 42


List Of Figure

List of Figures

GenePOC Inc Pipeline Products by Equipment Type 6

GenePOC Inc Pipeline Products by Development Stage 10

GenePOC Inc Ongoing Clinical Trials by Trial Status 13


List Of Table

List of Tables

GenePOC Inc Pipeline Products and Ongoing Clinical Trials Overview 5

GenePOC Inc Pipeline Products by Equipment Type 6

GenePOC Inc Pipeline Products by Indication 7

GenePOC Inc Ongoing Clinical Trials by Trial Status 7

GenePOC Inc, Key Facts 8

GenePOC Inc, Major Products and Services 9

GenePOC Inc Number of Pipeline Products by Development Stage 10

GenePOC Inc Pipeline Products Summary by Development Stage 11

GenePOC Inc Ongoing Clinical Trials by Trial Status 13

GenePOC Inc Ongoing Clinical Trials Summary 14

GenePOC GBS DS Assay-Product Status 15

GenePOC GBS DS Assay-Product Description 15

GenePOC GBS DS Assay-Prospective Study for Clinical Validation of the Molecular-based GenePOC Carba Assay for the Detection and Differentiation of Carbapenemase Genes of Gram-negative Bacteria (blaIMP, blaKPC, blaNDM, blaOXA-48-like and blaVIM) in Rectal Swab Samples From Patients Suspected of Being Colonized. The Targeted Organisms are Enterobacteriaceae, Acinetobacter Baumannii, and Pseudomonas Aeruginosa 16

revogene-Bacillus atrophaeus subsp. globigii Assay-Product Status 17

revogene-Bacillus atrophaeus subsp. globigii Assay-Product Description 17

revogene-Bacillus subtilis Assay-Product Status 18

revogene-Bacillus subtilis Assay-Product Description 18

revogene-Campylobacter jejuni Assay-Product Status 19

revogene-Campylobacter jejuni Assay-Product Description 19

revogene-Candida albicans Assay-Product Status 20

revogene-Candida albicans Assay-Product Description 20

revogene-Clostridium difficile Assay-Product Status 21

revogene-Clostridium difficile Assay-Product Description 21

revogene-Enterococcus faecalis Assay-Product Status 22

revogene-Enterococcus faecalis Assay-Product Description 22

revogene-Escherichia coli Assay-Product Status 23

revogene-Escherichia coli Assay-Product Description 23

revogene-Influenza A Assay-Product Status 24

revogene-Influenza A Assay-Product Description 24

revogene-Respiratory Tract Infections Assay-Product Status 25

revogene-Respiratory Tract Infections Assay-Product Description 25

revogene-Salmonella enterica Assay-Product Status 26

revogene-Salmonella enterica Assay-Product Description 26

revogene-Sexually Transmitted Infections Assay-Product Status 27

revogene-Sexually Transmitted Infections Assay-Product Description 27

revogene-Staphylococcus Assay-Product Status 28

revogene-Staphylococcus Assay-Product Description 28

Triplex Molecular Diagnostic Assay-Product Status 29

Triplex Molecular Diagnostic Assay-Product Description 29

GenePOC Inc, Key Employees 31

GenePOC Inc, Other Locations 32

Glossary 41

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License: 
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

To know more information on Purchase by Section, please send a mail to support@kenresearch.com

INQUIRE FOR COVID-19 IMPACT ANALYSIS

Products

GenePOC Inc, Product, Pipeline, Product Pipeline, Key Pipeline, Products by Equipment Type, Equipment Type, Therapy Area, Products by Therapy Area, Development Stage, Products by Development Stage, Milestone, Products by Milestone, Major Products, Brands, No of Products, Device Class, Market, Territory, Product Name, Therapy Name, Trial Name, Trial, Indication, Summary, Event Type, Clinical Trial, MileStone, Product Status, Product Description, Description, Patent, Patent Details, Competitors, Key Employees, Subsidiaries, Locations, News, Events, Developments, medical devices, business description, company facts, trial phase, approval, estimated, technology, product patent details, phase, trial status, trial objective, trial design, trial site, business strategies, trends, pipeline and technology, sales strategies


Companies

Xagenic Inc

Diagnostics Biochem Canada Inc

Rna Diagnostics Inc

Amico Corp